Loading insider details...
Beta
Latest Form 4 (Mar 4, 2026): Grant/Award of 9,500 CNSP shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 4, 2026 | CNS Pharmaceuticals, Inc. (CNSP) | Grant/Award | 9,500 | n/a |
| Apr 2, 2025 | Actinium Pharmaceuticals, Inc. (ATNM) | Disposition to Issuer | 3,333 | n/a |
| Dec 29, 2023 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 253,123 | n/a |
| Jul 1, 2022 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 256,438 | n/a |
| Sep 3, 2021 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 107,463 | n/a |
| Aug 14, 2020 | Actinium Pharmaceuticals, Inc. (ATNM) | Grant/Award | 59,066 | n/a |